1. Home
  2. ERIC vs BNTX Comparison

ERIC vs BNTX Comparison

Compare ERIC & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERIC
  • BNTX
  • Stock Information
  • Founded
  • ERIC 1876
  • BNTX 2008
  • Country
  • ERIC Sweden
  • BNTX Germany
  • Employees
  • ERIC N/A
  • BNTX N/A
  • Industry
  • ERIC Radio And Television Broadcasting And Communications Equipment
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ERIC Technology
  • BNTX Health Care
  • Exchange
  • ERIC Nasdaq
  • BNTX Nasdaq
  • Market Cap
  • ERIC 27.5B
  • BNTX 25.0B
  • IPO Year
  • ERIC N/A
  • BNTX 2019
  • Fundamental
  • Price
  • ERIC $8.55
  • BNTX $109.95
  • Analyst Decision
  • ERIC Hold
  • BNTX Strong Buy
  • Analyst Count
  • ERIC 1
  • BNTX 18
  • Target Price
  • ERIC $9.80
  • BNTX $141.55
  • AVG Volume (30 Days)
  • ERIC 16.4M
  • BNTX 771.1K
  • Earning Date
  • ERIC 07-15-2025
  • BNTX 08-04-2025
  • Dividend Yield
  • ERIC 2.11%
  • BNTX N/A
  • EPS Growth
  • ERIC N/A
  • BNTX N/A
  • EPS
  • ERIC 0.05
  • BNTX N/A
  • Revenue
  • ERIC $24,863,989,204.00
  • BNTX $2,968,331,171.00
  • Revenue This Year
  • ERIC $1.11
  • BNTX N/A
  • Revenue Next Year
  • ERIC $1.01
  • BNTX $10.68
  • P/E Ratio
  • ERIC $178.16
  • BNTX N/A
  • Revenue Growth
  • ERIC N/A
  • BNTX 0.61
  • 52 Week Low
  • ERIC $6.12
  • BNTX $76.53
  • 52 Week High
  • ERIC $9.00
  • BNTX $131.49
  • Technical
  • Relative Strength Index (RSI)
  • ERIC 56.50
  • BNTX 57.74
  • Support Level
  • ERIC $8.38
  • BNTX $105.35
  • Resistance Level
  • ERIC $8.57
  • BNTX $109.68
  • Average True Range (ATR)
  • ERIC 0.10
  • BNTX 2.56
  • MACD
  • ERIC 0.02
  • BNTX 0.05
  • Stochastic Oscillator
  • ERIC 91.07
  • BNTX 87.00

About ERIC Ericsson

Ericsson provides telecom equipment and services that are primarily used to build and facilitate mobile networks through operations in three segments: networks, cloud and software services, and enterprises. The firm's customers have historically been primarily wireless carriers, but the firm is making a push to cater more to other enterprises as well, both as they try to take advantage of 5G capabilities and on other "as-a-service" communications platforms. The company also licenses its patents to handset manufacturers so their devices are compatible with wireless networks.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Share on Social Networks: